You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
6 May 2025 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Tuesday that it has received European Commission approval for Calquence (acalabrutinib) in combination with bendamustine and rituximab as a first-...
6 May 2025 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Tuesday that the US Biomedical Advanced Research and Development Authority (BARDA) has exercised contract options totalling USD143.6m for the supply of its freeze...
6 May 2025 - Phanes Therapeutics Inc, a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced on Monday that the first patient has been dosed in the clinical study of peluntamig in combination with...
6 May 2025 - Beijing Tide Pharmaceutical Co Ltd, a subsidiary of China-based Sino Biopharmaceutical Limited (HK:1177), announced on Monday that it has achieved a milestone in developing its first-in-class analgesic drug (research code: TRD205), a hig...
6 May 2025 - Fangzhou Inc (HK:06086), a Chinese online chronic disease management platform, announced on Monday the availability of Otsuka Pharmaceutical's third-generation tyrosine kinase inhibitor (TKI) Iclusig (ponatinib) through its online p...
5 May 2025 - RNA oncology company TransCode Therapeutics Inc (Nasdaq:RNAZ) announced on Friday that its board of directors has approved a 1-for-28 reverse stock split.Approved by TransCode's stockholders on 2 May 2025, the reverse stock split is...
5 May 2025 - Seegene Inc, a South Korean provider of molecular diagnostics (MDx) solutions, announced on Friday that it has presented a conceptual video of its CURECA at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Gl...